<DOC>
	<DOCNO>NCT01844115</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety , tolerability vilazodone relative placebo treatment generalize anxiety disorder ( GAD ) .</brief_summary>
	<brief_title>Safety , Efficacy Tolerability Vilazodone ( GAD ) Generalized Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Vilazodone Hydrochloride</mesh_term>
	<criteria>Male female outpatient , 1870 year age Currently meet Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) criterion Generalized Anxiety Disorder Minimum score 20 Hamilton Rating Scale Anxiety Women pregnant breastfeeding study Patients history : 1 . Any manic hypomanic mixed episode , include bipolar disorder substanceinduced manic , hypomanic mixed episode 2 . Any depressive episode psychotic catatonic feature 3 . Panic disorder without agoraphobia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Generalized Anxiety Disorder , GAD</keyword>
</DOC>